Kratom

Subscribe to Kratom via RSS

FDA Continues Enforcement Action Against Kratom

Posted on May 24, 2021

FDA has warned consumers for years against using products containing Mitragyna speciosa, a plant from Southeast Asia that is commonly known as kratom, or its psychoactive compounds, mitragynine and

…
Continue Reading FDA Continues Enforcement Action Against Kratom

CSPI Urges FDA to Take Further Action on Tianeptine Products

Posted on August 28, 2020

On August 25, 2020, the Center for Science in the Public Interest (CSPI) sent a letter urging FDA to take further enforcement against manufacturers, distributors, and retailers that sell products

…
Continue Reading CSPI Urges FDA to Take Further Action on Tianeptine Products

FDA Issues Warning Letters to Companies Illegally Selling Unapproved, Misbranded Kratom Products

Posted on June 26, 2019

On June 25, FDA issued warning letters to two marketers and distributors of kratom products – Cali Botanicals and Kratom NC. FDA determined that the companies were illegally selling

…
Continue Reading FDA Issues Warning Letters to Companies Illegally Selling Unapproved, Misbranded Kratom Products

FDA Releases Heavy Metal Test Results in Kratom

Posted on April 5, 2019

In November 2018, FDA announced that it had tested 26 kratom products with “disturbingly” high heavy metal levels. Also known as Mitragyna speciose, kratom grows naturally in Southeast Asia

…
Continue Reading FDA Releases Heavy Metal Test Results in Kratom

FDA Finds High Levels of Heavy Metals in Kratom Products

Posted on November 30, 2018

In a press announcement released on November 27, 2018, FDA Commissioner Scott Gottlieb revealed that FDA scientists found “disturbingly” high levels of heavy metals in kratom products. Kratom, also known

…
Continue Reading FDA Finds High Levels of Heavy Metals in Kratom Products

FDA Announces Continued Kratom Safety Concerns and Issues Warning Letters to Kratom Marketers

Posted on September 12, 2018

In a press announcement released on September 11, 2018, FDA Commissioner Scott Gottlieb, M.D., emphasized the Agency’s continuing concerns about kratom products. Our readers may remember our previous posts about

…
Continue Reading FDA Announces Continued Kratom Safety Concerns and Issues Warning Letters to Kratom Marketers

FDA Continues its Enforcement Efforts Aimed at Companies Marketing Kratom Products

Posted on May 25, 2018

On May 22, 2018 FDA announced that it had issued warning letters to three companies marketing kratom products with medical claims. FDA’s letter asserts that the claims that the products

…
Continue Reading FDA Continues its Enforcement Efforts Aimed at Companies Marketing Kratom Products

FDA Issues First Ever Mandatory Recall Order for Kratom Products

Posted on April 4, 2018

On April 2, 2018, FDA issued a mandatory recall order for all products containing powdered kratom manufactured, processed, packed, or held by Triangle Pharmanaturals LLC, after several tested positive for

…
Continue Reading FDA Issues First Ever Mandatory Recall Order for Kratom Products